In conventional drug administration, drug molecules cross multiple biological barriers,
distribute randomly in the tissues, and can release insufficient concentrations at the desired …

Over the past decade, compared to all other macromolecules lipid-based nanocarriers have
proven to be an excellent carrier and delivery system for various pharmaceutical drugs of …

This review highlights the transformative impact of microfluidic technology on personalized
drug delivery. Microfluidics addresses issues in traditional drug synthesis, providing precise …

Coronary heart disease (CHD) is one of the major causes of death and disability worldwide,
especially in low-and middle-income countries and among older populations. Conventional …

Extracellular vesicles (EVs) mediate intercellular biomolecule exchanges in the body,
making them promising delivery vehicles for therapeutic cargo. Genetic engineering by the …

Nickel oxide (NiO) nanoparticles are essential to developing a wide range of important
industrial products, examples of which include electrodes, catalysts, and sensors, leading to …

Lipid nanoparticles (LNPs) have gained prominence as primary carriers for delivering a
diverse array of therapeutic agents. Biological products have achieved a solid presence in …

RNA therapeutics represents a powerful strategy for diseases where other approaches have
failed, especially given the recent successes of mRNA vaccines against the coronavirus …

Oral administration of nanoparticles (NPs) is a promising strategy to overcome solubility and
stability issues of many active compounds. However, this route faces major obstacles related …

Nanoparticles (NPs) have great potential as efficient drug delivery systems (DDSs) that have
been widely used in cancer therapy and vaccines especially in the past decade. The rise in …